Fed Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg
Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's midodrine HCl 5
mg tablets to Roberts ProAmatine® 5 mg tablets following a single, oral 5 mg (1 x 5 mg) dose
administration under fed conditions.